2011•Zhonghua putong waike zazhiRequires access

Combination treatment with bone mesenchymal stem cells and HGF gene therapy for limb ischemia of rabbit

Maohua Wang

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic effect of the combination treatment of bone mesenchymal stem cells(BMSC) and hepatocyte growth factor(HGF) gene therapy on limb ischemia of rabbits.Methods Ischemic model of hind limb was induced in the right hind limb of 32 New Zealand rabbits by ligation of the deep femoral artery and complete excision of the superficial femoral artery.After the model was established,the rabbits were equally randomized into empty plasmid treatment group(control group),BMSC treatment group(BMSC group),HGF gene therapy group(HGF group) and BMSC treatment plus HGF gene therapy group(BMSC+HGF group).All treatment regimens were administered by direct intramuscular injection into the operated limb.The collateral vessel count was performed using angiography 28 days after treatment,and the expression of CD31 and HGF in the muscle tissues surrounding the injection sites was detected by immunohistochemical staining and Western blot analysis respectively,30 days after treatment.Results The collateral vessel count showed no statistical difference in BMSC group or HGF group compared with control group,but it increased significantly in BMSC+HGF group compared with other 3 groups(P0.05 or P0.01).The immunohistochemical staining showed that the CD31 expression level of all the treated groups was significantly higher than that of the control group(P0.05 or P0.01),and CD31 expression had no significant difference between BMSC group and HGF group,but both of which were significantly lower than that of BMSC+HGF group(both P0.05).The Western blot demonstrated that the HGF expression level of all the treated groups was significantly higher than that of the control group(P0.05 or P0.01),and it was increased in the order of BMSC,HGF and BMSC+HGF group that all had statistical differences(all P0.05).Conclusions The combination treatment with BMSC and HGF gene therapy has synergistic effect that can effectively promote collateral vessel development,and thereby improve the perfusion of the ischemic limb of rabbit.

About this research paper

What this paper is about

Objective To investigate the therapeutic effect of the combination treatment of bone mesenchymal stem cells(BMSC) and hepatocyte growth factor(HGF) gene therapy on limb ischemia of rabbits.Methods Ischemic model of hind limb was induced in the right hind limb of 32 New Zealand rabbits by ligation of the deep femoral artery and complete excision of the superficial femoral artery.After the model was established,the rabbits were equally randomized into empty plasmid treatment group(control group),BMSC treatment group(BMSC group),HGF gene therapy group(HGF group) and BMSC treatment plus HGF gene therapy group(BMSC+HGF group).All treatment regimens were administered by direct intramuscular injection into the operated limb.The collateral vessel count was performed using angiography 28 days after treatment,and the expression of CD31 and HGF in the muscle tissues surrounding the injection sites was detected by immunohistochemical staining and Western blot analysis respectively,30 days after treatment.Results The collateral vessel count showed no statistical difference in BMSC group or HGF group compared with control group,but it increased significantly in BMSC+HGF group compared with other 3 groups(P0.05 or P0.01).The immunohistochemical staining showed that the CD31 expression level of all the treated groups was significantly higher than that of the control group(P0.05 or P0.01),and CD31 expression had no significant difference between BMSC group and HGF group,but both of which were significantly lower than that of BMSC+HGF group(both P0.05).The Western blot demonstrated that the HGF expression level of all the treated groups was significantly higher than that of the control group(P0.05 or P0.01),and it was increased in the order of BMSC,HGF and BMSC+HGF group that all had statistical differences(all P0.05).Conclusions The combination treatment with BMSC and HGF gene therapy has synergistic effect that can effectively promote collateral vessel development,and thereby improve the perfusion of the ischemic limb of rabbit.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic effect of the combination treatment of bone mesenchymal stem cells(BMSC) and hepatocyte growth factor(HGF) gene therapy on limb ischemia of rabbits.Methods Ischemic model of hind limb was induced in the right hind limb of 32 New Zealand rabbits by ligation of the deep femoral artery and complete excision of the superficial femoral artery.After the model was established,the rabbits were equally randomized into empty plasmid treatment group(control group),BMSC treatment group(BMSC group),HGF gene therapy group(HGF group) and BMSC treatment plus HGF gene therapy group(BMSC+HGF group).All treatment regimens were administered by direct intramuscular injection into the operated limb.The collateral vessel count was performed using angiography 28 days after treatment,and the expression of CD31 and HGF in the muscle tissues surrounding the injection sites was detected by immunohistochemical staining and Western blot analysis respectively,30 days after treatment.Results The collateral vessel count showed no statistical difference in BMSC group or HGF group compared with control group,but it increased significantly in BMSC+HGF group compared with other 3 groups(P0.05 or P0.01).The immunohistochemical staining showed that the CD31 expression level of all the treated groups was significantly higher than that of the control group(P0.05 or P0.01),and CD31 expression had no significant difference between BMSC group and HGF group,but both of which were significantly lower than that of BMSC+HGF group(both P0.05).The Western blot demonstrated that the HGF expression level of all the treated groups was significantly higher than that of the control group(P0.05 or P0.01),and it was increased in the order of BMSC,HGF and BMSC+HGF group that all had statistical differences(all P0.05).Conclusions The combination treatment with BMSC and HGF gene therapy has synergistic effect that can effectively promote collateral vessel development,and thereby improve the perfusion of the ischemic limb of rabbit.

Key concepts: Medicine, Hepatocyte growth factor, CD31, Mesenchymal stem cell, Femoral artery, Western blot, Immunohistochemistry, Genetic enhancement

Related papers

Back to paper searchBrowse research topicsOriginal source
Combination treatment with bone mesenchymal stem cells and HGF gene therapy for limb ischemia of rabbit — Research Paper | ScholarLens